T&R Biofab Balance Sheet Health
Financial Health criteria checks 3/6
T&R Biofab has a total shareholder equity of ₩22.9B and total debt of ₩35.8B, which brings its debt-to-equity ratio to 156.1%. Its total assets and total liabilities are ₩72.1B and ₩49.2B respectively.
Key information
156.1%
Debt to equity ratio
₩35.80b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩22.60b |
| Equity | ₩22.94b |
| Total liabilities | ₩49.19b |
| Total assets | ₩72.12b |
Recent financial health updates
Recent updates
Is T&R Biofab (KOSDAQ:246710) Using Debt Sensibly?
Feb 26
Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?
Mar 09Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?
Jan 12
Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?
Nov 18Financial Position Analysis
Short Term Liabilities: A246710's short term assets (₩29.6B) do not cover its short term liabilities (₩31.6B).
Long Term Liabilities: A246710's short term assets (₩29.6B) exceed its long term liabilities (₩17.6B).
Debt to Equity History and Analysis
Debt Level: A246710's net debt to equity ratio (57.6%) is considered high.
Reducing Debt: A246710's debt to equity ratio has increased from 0% to 156.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A246710 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A246710 has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 24.8% each year.